miRNAs: novel regulators of autoimmunity-mediated pancreatic β-cell destruction in type 1 diabetes

Clicks: 311
ID: 269771
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 5 articles by views in Cellular & molecular immunology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
MicroRNAs (miRNAs) are a series of conserved, short, non-coding RNAs that modulate gene expression in a posttranscriptional manner. miRNAs are involved in almost every physiological and pathological process. Type 1 diabetes (T1D) is an autoimmune disease that is the result of selective destruction o …
Reference Key
y2017cellularmirnas: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Zheng Y;Wang Z;Zhou Z;;
Journal Cellular & molecular immunology
Year 2017
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/28317889
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review immune system gene expression regulation animals humans pubmed abstract nih national institutes of health national library of medicine diabetes mellitus homeostasis cell death autoimmunity micrornas / genetics* pmid:28317889 pmc5518822 doi:10.1038/cmi.2017.7 ying zheng zhen wang zhiguang zhou type 1 / genetics* insulin-secreting cells / physiology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.